Peter Aronstam

Chief Financial Officer at Cytocom

Mr. Aronstam brings more than 30 years of experience in accounting, finance, banking, international trade, and law to Cytocom, Inc.. He has held senior finance roles with growth and performance-driven enterprises—from startup technology and Internet companies to small service providers ($50 million) to very large international manufacturers ($25 billion) to global banks.

Mr. Aronstam has advised and/or served as CFO in both publicly held and privately owned businesses since 1978. These include startup venture-capital-backed entrepreneurial companies; manufacturing, technology, and service companies; and corporate and international banking. Other roles have included human resources and information technology functions along with raising more than $500 million in debt and equity for his companies and their customers.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Cytocom

Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel second-generation immune therapies to deliver immune homeostasis based on proprietary platforms. The company has four phases 3 ready programs in Crohn’s Disease, Fibromyalgia, MS, and Pancreatic Cancer.


Industries

Employees

11-50

Links